A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer
- Rixe, O.
- Franco, S.X.
- Yardley, D.A.
- Johnston, S.R.
- Martin, M.
- Arun, B.K.
- Letrent, S.P.
- Rugo, H.S.
ISSN: 0344-5704
Année de publication: 2009
Volumen: 64
Número: 6
Pages: 1139-1148
Type: Article